| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article
- Language: English
- [J Genet Couns] 2024 Jun; Vol. 33 (3), pp. 677-688. <i>Date of Electronic Publication: </i>2023 Aug 26.
- MeSH Terms: Genetic Counseling* ; Humans ; Australia ; Health Personnel / psychology ; Genetic Testing ; Vascular Malformations / genetics ; Vascular Malformations / diagnosis ; Female ; Attitude of Health Personnel ; Male
- References: Adams, D. M., & Ricci, K. W. (2019). Vascular anomalies: Diagnosis of complicated anomalies and new medical treatment options. Hematology/Oncology Clinics of North America, 33(3), 455–470. https://doi.org/10.1016/j.hoc.2019.01.011. ; Amyere, M., Revencu, N., Helaers, R., Pairet, E., Baselga, E., Cordisco, M., Chung, W., Dubois, J., Lacour, J. P., Martorell, L., Mazereeuw‐Hautier, J., Pyeritz, R. E., Amor, D. J., Bisdorff, A., Blei, F., Bombei, H., Dompmartin, A., Brooks, D., Dupont, J., … Vikkula, M. (2017). Germline loss‐of‐function mutations in EPHB4 cause a second form of capillary malformation‐arteriovenous malformation (CM‐AVM2) deregulating RAS‐MAPK signaling. Circulation, 136(11), 1037–1048. https://doi.org/10.1161/CIRCULATIONAHA.116.026886. ; Barclay, S. F., Inman, K. W., Luks, V. L., McIntyre, J. B., al‐Ibraheemi, A., Church, A. J., Perez‐Atayde, A. R., Mangray, S., Jeng, M., Kreimer, S. R., Walker, L., Fishman, S. J., Alomari, A. I., Chaudry, G., Trenor Iii, C. C., Adams, D., Kozakewich, H. P. W., & Kurek, K. C. (2019). A somatic activating NRAS variant associated with kaposiform lymphangiomatosis. Genetics in Medicine, 21(7), 1517–1524. https://doi.org/10.1038/s41436‐018‐0390‐0. ; Ben Moshe, Y., Ladha, F., & Sisley, S. (2022). eP252: A multidisciplinary endocrine‐genetic obesity clinic for children: Diagnostic utility and insights. Genetics in Medicine, 24(3), S160. https://doi.org/10.1016/j.gim.2022.01.287. ; Bensend, T. A., Veach, P. M., & Niendorf, K. B. (2014). What's the harm? Genetic counselor perceptions of adverse effects of genetics service provision by non‐genetics professionals. Journal of Genetic Counseling, 23(1), 48–63. https://doi.org/10.1007/s10897‐013‐9605‐3. ; Biesecker, B. (2020). Genetic counseling and the central tenets of practice. Cold Spring Harbor Perspectives in Medicine, 10(3), a038968. https://doi.org/10.1101/cshperspect.a038968. ; Blatt, J., McLean, T. W., Castellino, S. M., & Burkhart, C. N. (2013). A review of contemporary options for medical management of hemangiomas, other vascular tumors, and vascular malformations. Pharmacology & Therapeutics, 139(3), 327–333. https://doi.org/10.1016/j.pharmthera.2013.05.001. ; Borst, A. J., Nakano, T. A., Blei, F., Adams, D. M., & Duis, J. (2020). A primer on a comprehensive genetic approach to vascular anomalies. Frontiers in Pediatrics, 8, 579591. https://doi.org/10.3389/fped.2020.579591. ; Bradbury, A. R., Patrick‐Miller, L., & Domchek, S. (2015). Multiplex genetic testing: Reconsidering utility and informed consent in the era of next‐generation sequencing. Genetics in Medicine, 17(2), 97–98. https://doi.org/10.1038/gim.2014.85. ; Braun, V., & Clarke, V. (2021). To saturate or not to saturate? Questioning data saturation as a useful concept for thematic analysis and sample‐size rationales. Qualitative Research in Sport, Exercise and Health, 13(2), 201–216. https://doi.org/10.1080/2159676X.2019.1704846. ; Braun, V., & Clarke, V. (2022). Conceptual and design thinking for thematic analysis. Qualitative Psychology, 9, 3–26. https://doi.org/10.1037/qup0000196. ; Burns, B. L., Bilkey, G. A., Coles, E. P., Bowman, F. L., Beilby, J. P., Pachter, N. S., Baynam, G., Dawkins, H. J. S., Weeramanthri, T. S., & Nowak, K. J. (2019). Healthcare system priorities for successful integration of genomics: An Australian focus. Frontiers in Public Health, 7, 41. https://doi.org/10.3389/fpubh.2019.00041. ; Butnariu, L. I., Gorduza, E. V., Florea, L., Țarcă, E., Moisă, Ș. M., Trandafir, L. M., Stoleriu, S., Bădescu, M. C., Luca, A.‐C., Popa, S., Radu, I., & Cojocaru, E. (2022). The genetic architecture of vascular anomalies: Current data and future therapeutic perspectives correlated with molecular mechanisms. International Journal of Molecular Sciences, 23(20), 12199. Retrieved from https://www.mdpi.com/1422‐0067/23/20/12199. ; Christensen, K. D., Vassy, J. L., Jamal, L., Lehmann, L. S., Slashinski, M. J., Perry, D. L., Robinson, J. O., Blumenthal‐Barby, J., Feuerman, L. Z., Murray, M. F., Green, R. C., McGuire, A. L., & Team, F. t. M. P. (2016). Are physicians prepared for whole genome sequencing? A qualitative analysis. Clinical Genetics, 89(2), 228–234. https://doi.org/10.1111/cge.12626. ; Clark, H. M., Gamm, J., Huether, C. A., Buncher, C. R., Pfau, R. I. B., & Warren, N. S. (2006). Genetic counselors and research: Current practices and future directions. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 142C(4), 276–283. https://doi.org/10.1002/ajmg.c.30106. ; Côté, L., & Turgeon, J. (2005). Appraising qualitative research articles in medicine and medical education. Medical Teacher, 27(1), 71–75. https://doi.org/10.1080/01421590400016308. ; D'Agincourt‐Canning, L. (2001). Experiences of genetic risk: Disclosure and the gendering of responsibility. Bioethics, 15(3), 231–247. https://doi.org/10.1111/1467‐8519.00234. ; Dimond, R., Doheny, S., Ballard, L., & Clarke, A. (2022). Genetic testing and family entanglements. Social Science & Medicine, 298, 114857. https://doi.org/10.1016/j.socscimed.2022.114857. ; East, K. M., Cochran, M. E., Kelley, W. V., Greve, V., Finnila, C. R., Coleman, T., Jennings, M., Alexander, L., Rahn, E. J., Danila, M. I., Barsh, G., Korf, B., & Cooper, G. (2022). Education and training of non‐genetics providers on the return of genome sequencing results in a NICU setting. Journal of Personalized Medicine, 12(3), 405. ; Eerola, I., Boon, L. M., Mulliken, J. B., Burrows, P. E., Dompmartin, A., Watanabe, S., Vanwijck, R., & Vikkula, M. (2003). Capillary malformation‐arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. American Journal of Human Genetics, 73(6), 1240–1249. https://doi.org/10.1086/379793. ; Eljamri, S., MacArthur, C., Strub, G., Bly, R., Bonilla‐Velez, J., Rosenberg, T. L., & Padia, R. (2022). Genetic testing for vascular anomalies – American society of pediatric otolaryngology vascular anomalies task force practice patterns. International Journal of Pediatric Otorhinolaryngology, 163, 111363. https://doi.org/10.1016/j.ijporl.2022.111363. ; Feilzer, M. Y. (2010). Doing mixed methods research pragmatically: Implications for the rediscovery of pragmatism as a research paradigm. Journal of Mixed Methods Research, 4(1), 6–16. https://doi.org/10.1177/1558689809349691. ; Foster, M. W., Mulvihill, J. J., & Sharp, R. R. (2009). Evaluating the utility of personal genomic information. Genetics in Medicine, 11(8), 570–574. https://doi.org/10.1097/GIM.0b013e3181a2743e. ; Gammon, A., Jasperson, K., & Champine, M. (2016). Genetic basis of Cowden syndrome and its implications for clinical practice and risk management. The Application of Clinical Genetics, 9, 83–92. https://doi.org/10.2147/tacg.S41947. ; Green, T. E., MacGregor, D., Carden, S. M., Harris, R. V., Hewitt, C. A., Berkovic, S. F., Penington, A. J., Scheffer, I. E., & Hildebrand, M. S. (2021). Identification of a recurrent mosaic KRAS variant in brain tissue from an individual with nevus sebaceous syndrome. Cold Spring Harbor Molecular Case Studies, 7(6), a006133. https://doi.org/10.1101/mcs.a006133. ; Greene, A. K., & Goss, J. A. (2018). Vascular anomalies: From a Clinicohistologic to a genetic framework. Plastic and Reconstructive Surgery, 141(5), 709e–717e. https://doi.org/10.1097/prs.0000000000004294. ; Hallowell, N., Arden‐Jones, A., Eeles, R., Foster, C., Lucassen, A., Moynihan, C., & Watson, M. (2006). Guilt, blame and responsibility: men's understanding of their role in the transmission of BRCA1/2 mutations within their family. Sociology of Health & Illness, 28(7), 969–988. ; Helm, B. M., Freeze, S. L., Spoonamore, K. G., Ware, S. M., Ayers, M. D., & Kean, A. C. (2018). The genetic counselor in the pediatric arrhythmia clinic: Review and assessment of services. Journal of Genetic Counseling, 27(3), 558–564. ; Hildebrand, M. S., Harvey, A. S., Malone, S., Damiano, J. A., do, H., Ye, Z., McQuillan, L., Maixner, W., Kalnins, R., Nolan, B., Wood, M., Ozturk, E., Jones, N. C., Gillies, G., Pope, K., Lockhart, P. J., Dobrovic, A., Leventer, R. J., Scheffer, I. E., & Berkovic, S. F. (2018). Somatic GNAQ mutation in the forme fruste of Sturge‐weber syndrome. Neurology Genetics, 4(3), e236. https://doi.org/10.1212/nxg.0000000000000236. ; Hoskinson, D. C., Dubuc, A. M., & Mason‐Suares, H. (2017). The current state of clinical interpretation of sequence variants. Current Opinion in Genetics & Development, 42, 33–39. https://doi.org/10.1016/j.gde.2017.01.001. ; Kentwell, M., Dow, E., Antill, Y., Wrede, C. D., McNally, O., Higgs, E., Hamilton, A., Ananda, S., Lindeman, G. J., & Scott, C. L. (2017). Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics. Gynecologic Oncology, 145(1), 130–136. ; Kohler, J. N., Turbitt, E., & Biesecker, B. B. (2017). Personal utility in genomic testing: A systematic literature review. European Journal of Human Genetics, 25(6), 662–668. https://doi.org/10.1038/ejhg.2017.10. ; Kunimoto, K., Yamamoto, Y., & Jinnin, M. (2022). ISSVA classification of vascular anomalies and molecular biology. International Journal of Molecular Sciences, 23(4), 2358. https://doi.org/10.3390/ijms23042358. ; Lalonde, E., Ebrahimzadeh, J., Rafferty, K., Richards‐Yutz, J., Grant, R., Toorens, E., Marie Rosado, J., Schindewolf, E., Ganguly, T., Kalish, J. M., Deardorff, M. A., & Ganguly, A. (2019). Molecular diagnosis of somatic overgrowth conditions: A single‐center experience. Molecular Genetics & Genomic Medicine, 7(3), e536. https://doi.org/10.1002/mgg3.536. ; Leong, K. F. (2021). Genetics of vascular malformations: Current perspectives. Indian Journal of Paediatric Dermatology, 22(1), 1–11. https://doi.org/10.4103/ijpd.IJPD_175_20. ; Lewis, C., Sanderson, S., Hill, M., Patch, C., Searle, B., Hunter, A., & Chitty, L. S. (2020). Parents' motivations, concerns and understanding of genome sequencing: A qualitative interview study. European Journal of Human Genetics, 28, 1–11. ; Li, M. M., Datto, M., Duncavage, E. J., Kulkarni, S., Lindeman, N. I., Roy, S., Tsimberidou, A. M., Vnencak‐Jones, C. L., Wolff, D. J., Younes, A., & Nikiforova, M. N. (2017). Standards and guidelines for the interpretation and reporting of sequence variants in cancer: A joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. The Journal of Molecular Diagnostics, 19(1), 4–23. https://doi.org/10.1016/j.jmoldx.2016.10.002. ; Limaye, N., Boon, L. M., & Vikkula, M. (2009). From germline towards somatic mutations in the pathophysiology of vascular anomalies. Human Molecular Genetics, 18(R1), R65–R74. https://doi.org/10.1093/hmg/ddp002. ; Lupo, P. J., Robinson, J. O., Diamond, P. M., Jamal, L., Danysh, H. E., Blumenthal‐Barby, J., Lehmann, L. S., Vassy, J. L., Christensen, K. D., Green, R. C., McGuire, A., & MedSeq Project team. (2016). Patients' perceived utility of whole‐genome sequencing for their healthcare: Findings from the MedSeq project. Personalized Medicine, 13(1), 13–20. https://doi.org/10.2217/pme.15.45. ; Mattassi, R., Manara, E., Colombo, P. G., Manara, S., Porcella, A., Bruno, G., Bruson, A., & Bertelli, M. (2018). Variant discovery in patients with mendelian vascular anomalies by next‐generation sequencing and their use in patient clinical management. Journal of Vascular Surgery, 67(3), 922–932.e11. https://doi.org/10.1016/j.jvs.2017.02.034. ; Morgan, D. D., Litster, C., Winsall, M., Devery, K., & Rawlings, D. (2021). “It's given me confidence”: A pragmatic qualitative evaluation exploring the perceived benefits of online end‐of‐life education on clinical care. BMC Palliative Care, 20(1), 57. https://doi.org/10.1186/s12904‐021‐00753‐y. ; Munden, A., Butschek, R., Tom, W. L., Marshall, J. S., Poeltler, D. M., Krohne, S. E., Alió, A. B., Ritter, M., Friedlander, D. F., Catanzarite, V., Mendoza, A., Smith, L., Friedlander, M., & Friedlander, S. F. (2014). Prospective study of infantile haemangiomas: Incidence, clinical characteristics and association with placental anomalies. The British Journal of Dermatology, 170(4), 907–913. https://doi.org/10.1111/bjd.12804. ; Nisselle, A., King, E. A., McClaren, B., Janinski, M., Metcalfe, S., & Gaff, C. (2021). Measuring physician practice, preparedness and preferences for genomic medicine: A national survey. BMJ Open, 11(7), e044408. https://doi.org/10.1136/bmjopen‐2020‐044408. ; Nowell, L. S., Norris, J. M., White, D. E., & Moules, N. J. (2017). Thematic Analysis:Striving to Meet the Trustworthiness Criteria. International Journal of Qualitative Methods, 16(1), 1609406917733847. https://doi.org/10.1177/1609406917733847. ; Oderich, G. S., Sullivan, T. M., Bower, T. C., Gloviczki, P., Miller, D. V., Babovic‐Vuksanovic, D., Macedo, T. A., & Stanson, A. (2007). Vascular abnormalities in patients with neurofibromatosis syndrome type I: Clinical spectrum, management, and results. Journal of Vascular Surgery, 46(3), 475–484. https://doi.org/10.1016/j.jvs.2007.03.055. ; O'Shea, R., Rankin, N. M., Kentwell, M., Gleeson, M., Salmon, L., Tucker, K. M., Lewis, S., & Taylor, N. (2020). How can Australia integrate routine genetic sequencing in oncology: A qualitative study through an implementation science lens. Genetics in Medicine, 22(9), 1507–1516. https://doi.org/10.1038/s41436‐020‐0838‐x. ; Owusu Obeng, A., Fei, K., Levy, K. D., Elsey, A. R., Pollin, T. I., Ramirez, A. H., Weitzel, K. W., & Horowitz, C. R. (2018). Physician‐reported benefits and barriers to clinical implementation of genomic medicine: A multi‐site IGNITE‐network survey. Journal of Personalized Medicine, 8(3), 24. https://doi.org/10.3390/jpm8030024. ; Palinkas, L. A., Horwitz, S. M., Green, C. A., Wisdom, J. P., Duan, N., & Hoagwood, K. (2015). Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Administration and Policy in Mental Health, 42(5), 533–544. https://doi.org/10.1007/s10488‐013‐0528‐y. ; Pasquier, L., Minguet, G., Moisdon‐Chataigner, S., Jarno, P., Denizeau, P., Volf, G., & Moutel, G. (2022). How do non‐geneticist physicians deal with genetic tests? A qualitative analysis. European Journal of Human Genetics, 30(3), 320–331. https://doi.org/10.1038/s41431‐021‐00884‐z. ; Patch, C., & Middleton, A. (2018). Genetic counselling in the era of genomic medicine. British Medical Bulletin, 126(1), 27–36. https://doi.org/10.1093/bmb/ldy008. ; Ramanadhan, S., Revette, A. C., Lee, R. M., & Aveling, E. L. (2021). Pragmatic approaches to analyzing qualitative data for implementation science: An introduction. Implementation Science Communications, 2(1), 70. https://doi.org/10.1186/s43058‐021‐00174‐1. ; Ren, A. A., Snellings, D. A., Su, Y. S., Hong, C. C., Castro, M., Tang, A. T., Detter, M. R., Hobson, N., Girard, R., Romanos, S., Lightle, R., Moore, T., Shenkar, R., Benavides, C., Beaman, M. M., Müller‐Fielitz, H., Chen, M., Mericko, P., Yang, J., … Kahn, M. L. (2021). PIK3CA and CCM mutations fuel cavernomas through a cancer‐like mechanism. Nature, 594(7862), 271–276. https://doi.org/10.1038/s41586‐021‐03562‐8. ; Seront, E., Van Damme, A., Boon, L. M., & Vikkula, M. (2019). Rapamycin and treatment of venous malformations. Current Opinion in Hematology, 26(3), 185–192. https://doi.org/10.1097/moh.0000000000000498. ; Siegel, D. H., Cottrell, C. E., Streicher, J. L., Schilter, K. F., Basel, D. G., Baselga, E., Burrows, P. E., Ciliberto, H. M., Vigh‐Conrad, K. A., Eichenfield, L. F., Holland, K. E., Hogeling, M., Jensen, J. N., Kelly, M. E., Kim, W., King, D. M., McCuaig, C., Mueller, K. A., Pope, E., … Drolet, B. A. (2018). Analyzing the genetic Spectrum of vascular anomalies with overgrowth via cancer genomics. The Journal of Investigative Dermatology, 138(4), 957–967. https://doi.org/10.1016/j.jid.2017.10.033. ; Steiner, J. E., & Drolet, B. A. (2017). Classification of vascular anomalies: An update. Seminars in Interventional Radiology, 34(3), 225–232. https://doi.org/10.1055/s‐0037‐1604295. ; Sukhai, M. A., Craddock, K. J., Thomas, M., Hansen, A. R., Zhang, T., Siu, L., Bedard, P., Stockley, T. L., & Kamel‐Reid, S. (2016). A classification system for clinical relevance of somatic variants identified in molecular profiling of cancer. Genetics in Medicine, 18(2), 128–136. https://doi.org/10.1038/gim.2015.47. ; Sukhai, M. A., Misyura, M., Thomas, M., Garg, S., Zhang, T., Stickle, N., Virtanen, C., Bedard, P. L., Siu, L. L., Smets, T., Thijs, G., van Vooren, S., Kamel‐Reid, S., & Stockley, T. L. (2019). Somatic tumor variant filtration strategies to optimize tumor‐only molecular profiling using targeted next‐generation sequencing panels. The Journal of Molecular Diagnostics, 21(2), 261–273. https://doi.org/10.1016/j.jmoldx.2018.09.008. ; Tole, S., Fantauzzi, M., Cottingham, D., Amaral, J. G., John, P. R., Lara‐Corrales, I., Pope, E., & Carcao, M. D. (2021). The use of rapamycin to treat vascular tumours and malformations: A single‐Centre experience. Paediatrics & Child Health, 26(1), e25–e32. https://doi.org/10.1093/pch/pxz090. ; Ustaszewski, A., Janowska‐Głowacka, J., Wołyńska, K., Pietrzak, A., & Badura‐Stronka, M. (2021). Genetic syndromes with vascular malformations ‐ update on molecular background and diagnostics. Archives of Medical Science, 17(4), 965–991. https://doi.org/10.5114/aoms.2020.93260. ; Wakefield, E., Keller, H., Mianzo, H., Nagaraj, C. B., Tawde, S., & Ulm, E. (2018). Reduction of health care costs and improved appropriateness of incoming test orders: The impact of genetic counselor review in an academic genetic testing laboratory. Journal of Genetic Counseling, 27(5), 1067–1073. ; Wassef, M., Blei, F., Adams, D., Alomari, A., Baselga, E., Berenstein, A., Burrows, P., Frieden, I. J., Garzon, M. C., Lopez‐Gutierrez, J. C., Lord, D. J., Mitchel, S., Powell, J., Prendiville, J., Vikkula, M., & ISSVA Board and Scientific Committee. (2015). Vascular anomalies classification: Recommendations from the International Society for the Study of vascular anomalies. Pediatrics, 136(1), e203–e214. https://doi.org/10.1542/peds.2014‐3673. ; Wouters, V., Limaye, N., Uebelhoer, M., Irrthum, A., Boon, L. M., Mulliken, J. B., Enjolras, O., Baselga, E., Berg, J., Dompmartin, A., Ivarsson, S. A., Kangesu, L., Lacassie, Y., Murphy, J., Teebi, A. S., Penington, A., Rieu, P., & Vikkula, M. (2010). Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper‐phosphorylating effects. European Journal of Human Genetics, 18(4), 414–420. https://doi.org/10.1038/ejhg.2009.193. ; Yogasundaram, H., Alhumaid, W., Dzwiniel, T., Christian, S., & Oudit, G. Y. (2021). Cardiomyopathies and genetic testing in heart failure: Role in defining phenotype‐targeted approaches and management. Canadian Journal of Cardiology, 37(4), 547–559. https://doi.org/10.1016/j.cjca.2021.01.016.
- Contributed Indexing: Keywords: complex disease; genetic counseling; genetic counselors; genetic testing; multidisciplinary teams; vascular anomalies
- Entry Date(s): Date Created: 20230826 Date Completed: 20240618 Latest Revision: 20240618
- Update Code: 20240618
|
